Zimmer Biomet Holdings, Inc. (ZBH)
Largest Insider Buys in Sector
ZBH Stock Price History Chart
ZBH Stock Performance
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate …
Insider Activity of Zimmer Biomet Holdings, Inc.
Over the last 12 months, insiders at Zimmer Biomet Holdings, Inc. have bought $0 and sold $5.06M worth of Zimmer Biomet Holdings, Inc. stock.
On average, over the past 5 years, insiders at Zimmer Biomet Holdings, Inc. have bought $485,817 and sold $3.93M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,135 shares for transaction amount of $223,641 was made by Jafry Syed A. (director) on 2023‑11‑09.
List of Insider Buy and Sell Transactions, Zimmer Biomet Holdings, Inc.
| 2024-05-31 | Sale | Group President, Asia Pacific | 12,857 0.0062% | $114.69 | $1.47M | -6.04% | ||
| 2024-03-07 | Sale | Group President, Asia Pacific | 1,705 0.0008% | $126.86 | $216,296 | -12.75% | ||
| 2024-02-22 | Sale | Sr. VP/Gen Counsel/Secretary | 26,156 0.0125% | $128.62 | $3.36M | -12.85% | ||
| 2023-11-09 | director | 2,135 0.001% | $104.75 | $223,641 | +12.82% | |||
| 2023-08-30 | director | 1,000 0.0005% | $120.37 | $120,370 | -0.84% | |||
| 2023-08-28 | director | 2,000 0.0009% | $116.48 | $232,960 | +1.54% | |||
| 2023-08-28 | director | 1,000 0.0005% | $117.11 | $117,114 | +1.54% | |||
| 2023-08-25 | director | 871 0.0004% | $114.84 | $100,023 | +3.59% | |||
| 2023-08-25 | director | 1,300 0.0006% | $115.50 | $150,150 | +3.59% | |||
| 2023-08-23 | director | 1,000 0.0005% | $115.61 | $115,613 | +3.91% | |||
| 2023-03-17 | Sale | Sr. VP/Gen Counsel/Secretary | 23,045 0.011% | $124.50 | $2.87M | +0.40% | ||
| 2022-12-13 | Sale | Sr. VP/Gen Counsel/Secretary | 11,522 0.0055% | $128.63 | $1.48M | -1.89% | ||
| 2022-07-01 | Sale | Pres, Europe, M. East & Africa | 531 0.0002% | $105.22 | $55,870 | +15.99% | ||
| 2022-03-17 | Sale | Sr. VP/Gen Counsel/Secretary | 29,518 0.0141% | $121.90 | $3.6M | -2.98% | ||
| 2021-12-14 | Sale | President, Asia Pacific | 5,600 0.0027% | $124.14 | $695,198 | -2.36% | ||
| 2021-05-06 | director | 2,000 0.0005% | $85.79 | $171,580 | -18.81% | |||
| 2020-11-18 | Sale | President, Asia Pacific | 2,400 0.0012% | $152.59 | $366,216 | +6.65% | ||
| 2020-11-09 | Sale | Sr. VP/Gen Counsel/Secretary | 60,080 0.0149% | $79.85 | $4.8M | +1.34% | ||
| 2020-05-29 | Sale | President, Asia Pacific | 6,000 0.0029% | $125.38 | $752,260 | +17.84% | ||
| 2020-05-13 | President and CEO | 2,000 0.001% | $113.00 | $226,000 | +32.20% |
Insider Historical Profitability
| Hanson Bryan C | President and CEO | 54568 0.0274% | $107.12 | 6 | 0 | +5.73% |
| GLASSCOCK LARRY C | director | 8593 0.0043% | $107.12 | 1 | 4 | +11.99% |
| BERNARD BETSY J | director | 5271 0.0026% | $107.12 | 3 | 0 | +14.12% |
| HAGEMANN ROBERT | director | 4000 0.002% | $107.12 | 2 | 0 | +13.96% |
| Jafry Syed A. | director | 4060 0.002% | $107.12 | 2 | 0 | +9.03% |
Institutional Investor Ownership
| The Vanguard Group | $3.14B | 11.56 | 23.77M | -0.36% | -$11.41M | 0.06 | |
| BlackRock | $2.28B | 8.4 | 17.28M | -7.64% | -$188.65M | 0.05 | |
| Dodge & Cox | $2.17B | 7.98 | 16.42M | +43.09% | +$652.61M | 1.26 | |
| T. Rowe Price | $1.4B | 5.17 | 10.64M | +12.9% | +$160.48M | 0.17 | |
| State Street | $1.23B | 4.52 | 9.31M | -0.06% | -$752,719.91 | 0.05 |